Timo Sarajarvi

Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations.

Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations.

Journal: Neuropharmacology

Published: March 27, 2018

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease.

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease.

Journal: Stem cell reports

Published: June 11, 2017

Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.

Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.

Journal: Journal of Alzheimer's disease : JAD

Published: November 02, 2016

SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.

SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.

Journal: Journal of cell science

Published: December 23, 2015

Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease.

Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease.

Journal: Neurochemistry international

Published: October 14, 2015

Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer's Disease.

Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: September 25, 2015

Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.

Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.

Journal: Neurobiology of disease

Published: January 26, 2015

Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.

Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.

Journal: Journal of Alzheimer's disease : JAD

Published: August 07, 2014

Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.

Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.

Journal: Neurobiology of aging

Published: May 07, 2014

Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology.

Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology.

Journal: PloS one

Published: January 10, 2014

Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease.

Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease.

Journal: PloS one

Published: September 09, 2013

Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease.

Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: August 24, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026